Severe refractory hemorrhagic cystitis after hematopoietic cell transplantation responds to recombinant human keratinocyte growth factor-Case report and review of the literature

Pediatr Blood Cancer. 2023 Oct;70(10):e30606. doi: 10.1002/pbc.30606. Epub 2023 Aug 2.

Authors

Catherine Hughes¹, Anora Harris¹, Benjamin Watkins¹, Muna Qayed¹, Suhag Parikh¹, Edwin Horwitz¹, Elizabeth Stenger¹, Kirsten M Williams¹, Michelle L Schoettler¹

Affiliation

¹ Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Division of Pediatrics, Emory University, Atlanta, Georgia, USA.

PMID: 37533091
DOI: 10.1002/pbc.30606

No abstract available

Publication types

Review
Case Reports
Letter

MeSH terms

BK Virus*
Cystitis* / drug therapy
Cystitis* / etiology
Fibroblast Growth Factor 7
Hematopoietic Stem Cell Transplantation* / adverse effects
Hemorrhage / complications
Hemorrhage / therapy
Humans
Polyomavirus Infections* / complications

Substances

Fibroblast Growth Factor 7